What's scary is nobody is even talking about Novel which could sell at any time for 10 million or more and nobody is talking about Lodrane which is owned by Elite and is currently in scale-up.
These are two HUGE items but are currently taking a back seat to the upcoming partner for our ART, the commencement of clinical trials, partnership for the new ANDA's, and launch of 11 new already approved ANDA's.